COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $497 | -3.7% | 15,430 | +16.0% | 0.00% | 0.0% |
| Q1 2024 | $516 | +34.4% | 13,298 | +6.6% | 0.00% | 0.0% |
| Q4 2023 | $384 | +69.9% | 12,474 | +23.2% | 0.00% | 0.0% |
| Q3 2023 | $226 | +1.8% | 10,124 | -1.9% | 0.00% | – |
| Q2 2023 | $222 | -6.3% | 10,324 | +4.6% | 0.00% | -100.0% |
| Q1 2023 | $237 | -0.4% | 9,874 | -3.9% | 0.00% | 0.0% |
| Q4 2022 | $238 | -99.9% | 10,274 | 0.0% | 0.00% | – |
| Q3 2022 | $165,000 | -9.3% | 10,274 | 0.0% | 0.00% | – |
| Q2 2022 | $182,000 | -35.7% | 10,274 | -26.2% | 0.00% | -100.0% |
| Q1 2022 | $283,000 | +7.6% | 13,913 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | -3.3% | 14,103 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $272,000 | -12.5% | 13,797 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $311,000 | +17.4% | 13,157 | +17.8% | 0.00% | 0.0% |
| Q1 2021 | $265,000 | – | 11,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |